
Reporting of Noninferiority and Equivalence Randomized Trials: An Extension of the CONSORT StatementCorrection
JAMA. 2006;296:1842.
Incorrect Formula: In the Special Communication entitled "Reporting of Noninferiority and Equivalence Randomized Trials: An Extension of the CONSORT Statement" published in the March 8, 2006, issue of JAMA (2006;295:1152-1160), a formula for a 2-sided confidence interval (CI) used to assess noninferiority of a new treatment compared with a standard one with regard to an outcome was incorrect. On page 1158 in the subsection titled "Elaboration" that reads "the upper bound of the 2-sided (1 /2) x 100% CI for the treatment effect has to be below the margin to declare that noninferiority has been shown . . . " should read "the upper bound of the 2-sided (1 2 ) x 100% CI for the treatment effect has to be below the margin to declare that noninferiority has been shown . . . "
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder
Allgulander et al.
J Psychopharmacol 2008;22:417-425.
ABSTRACT
|